Benitec Biopharma Inc. BNTC
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -12.81M | -11.94M | -11.84M | -8.97M | -8.81M |
| Total Depreciation and Amortization | 124.00K | 119.00K | 120.00K | 118.00K | 118.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.26M | 7.59M | 7.38M | 5.18M | 6.11M |
| Change in Net Operating Assets | 1.49M | -228.00K | 562.00K | 316.00K | -5.64M |
| Cash from Operations | -4.94M | -4.45M | -3.78M | -3.35M | -8.21M |
| Capital Expenditure | -79.00K | -15.00K | -11.00K | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -79.00K | -15.00K | -11.00K | -- | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 241.00K | 507.00K | 104.50M | -- | 2.82M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -1.00K | -6.27M | -- | -72.00K |
| Cash from Financing | 241.00K | 506.00K | 98.23M | -- | 2.74M |
| Foreign Exchange rate Adjustments | -12.00K | -67.00K | -132.00K | 86.00K | -120.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.79M | -4.03M | 94.31M | -3.27M | -5.59M |